Completed Trial: Structured Exercise Prescription with Smartwatch Monitoring vs Usual Care in High-Risk Pregnancies — Outcomes Across GDM, Hypertension, and Obesity

References

1. 1.American College of Obstetricians and Gynecologists. (2020). ACOG Committee Opinion No. 804: Physical activity and exercise during pregnancy and the postpartum period. Obstetrics & Gynecology, 135(4), e178–e188. https://doi.org/10.1097/AOG.0000000000003772
2. 2.Bramham, K., Parnell, B., Nelson-Piercy, C., Seed, P. T., Poston, L., & Chappell, L. C. (2014). Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ, 348, g2301. https://doi.org/10.1136/bmj.g2301
3. 3.Nagpal, T. S., Mottola, M. F., Bergeron, M. F., & Prapavessis, H. (2022). Wearable technology to promote physical activity during pregnancy: A systematic review and meta-analysis. British Journal of Sports Medicine, 56(6), 332–342. https://doi.org/10.1136/bjsports-2021-104440
4. 4.Royal Australian and New Zealand College of Obstetricians and Gynaecologists. (2020). Exercise in pregnancy (C-Obs 62). RANZCOG. https://ranzcog.edu.au/statements-guidelines/obstetrics/exercise-in-pregnancy
5. 5.Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., Pavkov, M. E., Ramachandaran, A., Wild, S. H., James, S., Herman, W. H., Zhang, P., Bommer, C., Kuo, S., Boyko, E. J., & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
6. 6.Unidade Local de Saúde de Coimbra, EPE. (2025). Impact of exercise prescription on obstetric and neonatal outcomes (NCT07678944). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07678944